Found: 1
Select item for more details and to access through your institution.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Select item for more details and to access through your institution.